Gene · 1890
Papers4,467
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 4,467
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Short-term efficacy and influencing factors of conventional chemotherapy combined with irinotecan in patients with advanced gastric cancer. | World J Gastrointest Oncol | 2023 | 36684052 | PubTator, text mining | PubMed |
| Survival and Toxicities of Metastatic Colorectal Cancer Patients Treated with Regorafenib before TAS-102 or Vice Versa: A Mono-Institutional Real-Practice Study. | J Clin Med | 2023 | 36675525 | PubTator, text mining | PubMed |
| Adipose Tissue-Derived Extracellular Vesicles Contribute to Phenotypic Plasticity of Prostate Cancer Cells. | Int J Mol Sci | 2023 | 36674745 | PubTator, text mining | PubMed |
| Druggable Biomarkers Altered in Clear Cell Renal Cell Carcinoma: Strategy for the Development of Mechanism-Based Combination Therapy. | Int J Mol Sci | 2023 | 36674417 | PubTator, text mining | PubMed |
| OxPhos defects cause hypermetabolism and reduce lifespan in cells and in patients with mitochondrial diseases. | Commun Biol | 2023 | 36635485 | PubTator, text mining | PubMed |
| Proteomic profiling of urinary small extracellular vesicles in children with pneumonia: a pilot study. | Pediatr Res | 2023 | 36635400 | PubTator, text mining | PubMed |
| Oxidative Stress and Immune Response in Melanoma: Ion Channels as Targets of Therapy. | Int J Mol Sci | 2023 | 36614330 | PubTator, text mining | PubMed |
| Quantitative proteomics analysis revealed the potential role of lncRNA Ftx in cardiomyocytes. | Proteome Sci | 2023 | 36604692 | PubTator, text mining | PubMed |
| Total coumarins of Pileostegia tomentella induces cell death in SCLC by reprogramming metabolic patterns, possibly through attenuating β-catenin/AMPK/SIRT1. | Chin Med | 2023 | 36597133 | PubTator, text mining | PubMed |
| Downregulation of LRP/LR with siRNA inhibits several cancer hallmarks in lung cancer cells. | FEBS Open Bio | 2023 | 36579897 | PubTator, text mining | PubMed |
| Identification of Potential Biomarkers Using Integrative Approach: A Case Study of ESCC. | SN Comput Sci | 2023 | 36573207 | PubTator, text mining | PubMed |
| Nuclear factor I-C overexpression promotes monocytic development and cell survival in acute myeloid leukemia. | Leukemia | 2023 | 36572750 | PubTator, text mining | PubMed |
| Genetic testing for mitochondrial disease: the United Kingdom best practice guidelines. | Eur J Hum Genet | 2023 | 36513735 | PubTator, text mining | PubMed |
| Capecitabine induces hand-foot syndrome through elevated thymidine phosphorylase-mediated locoregional toxicity and GSDME-driven pyroptosis that can be relieved by tipiracil. | Br J Cancer | 2023 | 36347964 | PubTator, text mining | PubMed |
| Triple-Negative PAM50 Non-Basal Breast Cancer Subtype Predicts Benefit from Extended Adjuvant Capecitabine. | Clin Cancer Res | 2023 | 36346687 | PubTator, text mining | PubMed |
| Proteomics reveals antiviral host response and NETosis during acute COVID-19 in high-risk patients. | Biochim Biophys Acta Mol Basis Dis | 2023 | 36328146 | PubTator, text mining | PubMed |
| A pilot study of agreement between noninvasive thermometers and the core temperature of postoperative cardiothoracic surgical patients. | Aust Crit Care | 2023 | 36123238 | PubTator, text mining | PubMed |
| Looking at NSAIDs from a historical perspective and their current status in drug repurposing for cancer treatment and prevention. | J Cancer Res Clin Oncol | 2023 | 35876951 | PubTator, text mining | PubMed |
| Crosslink between mutations in mitochondrial genes and brain disorders: implications for mitochondrial-targeted therapeutic interventions. | Neural Regen Res | 2023 | 35799515 | PubTator, text mining | PubMed |
| A "sweet" way to increase the metabolic activity and migratory response of cells associated with wound healing: deoxy-sugar incorporated polymer fibres as a bioactive wound patch. | Turk J Biol | 2022 | 37533670 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1890/papers?page=20